Cyberonics Receives FDA Real-Time Review Approval For New VNS Therapy Perennia Lead (Medical News Today)
Cyberonics, Inc. (Nasdaq:CYBX) today announced that it received FDA Real-Time Review approval forits new VNS Therapy(TM) Perennia(TM) Lead. The Perennia Lead, which isconnected to the VNS Therapy System Generator and attached to the leftvagus nerve, can be used with the current Model 102 and the futureDemipulse(TM) Pulse Generators (Models 103 and 104). [click link for full article]

Lupin Announces Approval Of Meloxicam Tablets (Medical News Today)
Lupin Pharmaceuticals, Inc.announced today that the U.S. Food and Drug Administration (FDA) hasgranted final approval for its Abbreviated New Drug Application (ANDA) forMeloxicam Tablets, 7.5 mg and 15 mg. The Company intends to initiateshipments immediately. Lupin's Meloxicam Tablets are the AB-rated generic equivalent ofBoehringer Ingelheim's MOBIC(R) Tablets. [click link for full article]

AtriCure Receives FDA 510(k) Clearance For Multifunctional Isolator(TM) Transpolar (TM) Pen System And Releases New (Medical News Today)
AtriCure, Inc. [click link for full article]